PharmaCyte Biotech, Inc. Common Stock
N/A
USD
N/A
N/A
...
Chart
Financials
Description
PMCB Company Description
PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology known as Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.
PMCB Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view PMCB Smart Score
Score Breakdown
PMCB Company Description
Show More
PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology known as Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer. Show Less
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of PMCB by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by PMCB's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
WallStreetBets
Number of mentions of PMCB in WallStreetBets Daily Discussion
PMCB News
Recent insights relating to PMCB
CNBC Recommendations
Recent picks made for PMCB stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in PMCB
Corporate Flights
Flights by private jets registered to PMCB
Our Analysis